Loading...
Loading...
Among the 6 tracked institutional investors we monitor, VTGN (VISTAGEN THERAPEUTICS INC) is held with a combined value of $2.23M across 3,604,963 shares. The largest holder is VANGUARD GROUP INC with a position worth $1.21M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 3 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$2.23M
Total Shares Held
3,604,963
Institutional Holders
6
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $1.21M | 0.00% | New |
| 2 | MILLENNIUM MANAGEMENT LLC | $368.28K | 0.00% | +227.0% |
| 3 | BlackRock, Inc. | $256.32K | 0.00% | +6.1% |
| 4 | RENAISSANCE TECHNOLOGIES LLC | $166.48K | 0.00% | +81.2% |
| 5 | CITADEL ADVISORS LLC | $157.11K | 0.00% | -67.7% |
| 6 | STATE STREET CORP | $69.22K | 0.00% | - |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of VTGN with a position worth $1.21M, representing 0.00% of their portfolio. In total, 6 institutional investors hold VTGN with a combined value of $2.23M.
In the most recent quarter, 1 fund opened a new position in VTGN. Additionally, 3 increased their holdings and 1 reduced their positions.
Institutional investors hold $2.23M worth of VTGN stock across 6 positions. The largest institutional holder is VANGUARD GROUP INC with $1.21M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For VTGN, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their VTGN positions.